Current Research in Colistin Therapeutic Drug Monitoring – Pre-eliminary Results of Investigator-Initiated Clinical Trial COL-ECMO2022

Varování

Publikace nespadá pod Fakultu sociálních studií, ale pod Lékařskou fakultu. Oficiální stránka publikace je na webu muni.cz.
Autoři

RYCHLÍČKOVÁ Jitka SUK Pavel

Rok publikování 2024
Druh Konferenční abstrakty
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
Popis Recap the shortcomings in colistin therapeutic drug monitoring (TDM) and summarize lessons learned from several follow-up projects that address these gaps. A literature review on colistin TDM. Development of a method for determining colistin/CMS in three matrices. Short-term stability tests of colistin and CMS in the above matrices. Preliminary results of a prospective, non-randomized, single-center phase IV pharmacokinetic clinical trial to assess the effect of ECMO on the pharmacokinetics of colistin and CMS (COL-ECMO2022 trial). The primary shortcomings in colistin TDM are the lack of a method for routine measurement, insufficient stability data for samples, a limited availability of the population pharmacokinetic models. A simple LC-MS/MS method for the determination of both substrates has been established and validated in the associated laboratory; it is currently the only facility in the Czech Republic capable of determining colistin and CMS in plasma/serum. The total analysis time is 5 minutes. Short-term stability data confirming a relationship between colistin/CMS stability and temperature/temperature and concentration provide valuable input for preanalytical sample processing. 23 Preliminary results of the pharmacokinetic study show a high colistin exposure despite standard dosage use. Colistin AUCSS,24h was 165±128 mg.h/L, cSS corresponds to 6.9±5.3 mg/L. Considering the variable relationship between CMS concentration and achieved colistin concentrations, the determination of colistin itself, especially trough concentration, seems to be crucial; the determination of CMS is not essential. Real-time TDM appears to be a fundamental condition for the rational use of colistin, and the above data helps with practical implementation.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.